Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pediatric Exclusivity Would Be Reduced To Three Months Under Bipartisan Bill

This article was originally published in The Pink Sheet Daily

Executive Summary

The Lower PRICED Drugs Act from Sens. Lott (R-Miss.) and Stabenow (D-Mich.) also proposes to expand generic competition to non-“Orange Book”-listed antibiotics and to revise how 30-month stays are applied.

You may also be interested in...



Rep. Waxman Becomes Key Legislator On Biopharma Issues With House Flip

The congressman will likely support follow-on biologics legislation and other reforms sought by the generic industry as chairman of Government Reform Committee and as a senior member of Energy & Commerce Committee.

Rep. Waxman Becomes Key Legislator On Biopharma Issues With House Flip

The congressman will likely support follow-on biologics legislation and other reforms sought by the generic industry as chairman of Government Reform Committee and as a senior member of Energy & Commerce Committee.

Generic Drug Review Backlog Criticized At Appropriations Hearing

Sen. Kohl (D-Wisc.) requests a report on FDA’s efforts to improve its generic approval process.

Topics

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel